 |
|
|
| |
Preclinical antiviral profile of AB-836, a potent, highly selective hepatitis B virus capsid inhibitor
|
| |
| |
EASL International Liver Congress, June 23-26, 2021 JNJ-3989
N Mani1*, AG Cole1, SG Kultgen1, A Ardzinski1, T Chiu1, A Cuconati1, BD Dorsey1, K Fan1, I Graves1, J-T Guo2, TO Harasym1, Z Hu2,
R Kowalski1, J Kunta1, AM Lam1, ACH Lee1, B Liu1, E Mesaros1,
R Rijnbrand1, HMM Steuer1, K Stever1, S Tang1, X Teng1, EP Thi1, and MJ Sofia1
1Arbutus Biopharma; 2Blumberg Institute
|
| |
|
|
|
|
|
